Home | Volume 34 | Article number 49

Original article

The way a nose could affect pregnancy: severe and recurrent epistaxis

The way a nose could affect pregnancy: severe and recurrent epistaxis

Laura Giambanco1,&, Vito Iannone1, Maddalena Borriello1, Giuseppe Scibilia2, Paolo Scollo2

 

1Ob&Gyn Department, S. Antonio Abate Hospital, Trapani, Italy, 2Ob&Gyn Department Cannizzaro Hospital, Catania, Italy

 

 

&Corresponding author
Laura Giambanco, Ob&Gyn Department, S. Antonio Abate Hospital, Trapani, Italy

 

 

Abstract

Massive and severe epistaxis is an uncommon event in pregnancy. It could be life threatening and could affect the normal pregnancy course. The best management is still on debate; it could be medical, conservative or surgical. Pregnancy termination often is problem solving. Hormonal changes during pregnancy affects nasal physiology. Vaginal delivery, labour induction or cesarean section are all suitable, after hemodynamic stabilization of pregnant woman. We report a case and review the available literature.

 

 

Introduction    Down

El Goulli et al. in 1979 [1] reported on a case of severe epistaxis in pregnancy with maternal collapse and fetal death. From then on few case reports have been published) [1-9] (Table 1) with different management of epistaxis in third trimester of pregnancy. Furthermore, the mode of delivery, vaginally or by cesarean section, varies in this short report, probably due to qualitative and quantitative levels of blood loss. Epistaxis is a common problem in pregnancy, secondary to an increased nasal mucosa vascularity. A large volume epistaxis is uncommon in women without risk factors (such as anticoagulants therapy or blood clotting disorders) [9]. When severe blood loss through the nose occurs in third trimester of pregnancy there are different therapeutical approaches: nose packing, hemostatic foam/sponge, cautery or diathermy, ligation of sphenopalatine artery. The acute blood loss could be life threatening both for mother and fetus. Hospitalization is mandatory, blood transfusion is often required, tranexamic acid intravenous therapy, ENT specialist (ear, nose, throat) intervention to manage epistaxis. Then, obstetricians have to decide if it's necessary to induce labour and if it's possible vaginal delivery. Theoretically, vaginal delivery could be contraindicated because of the efforts required, the pushes during the late second stage, Valsalva maneuvers may induce epistaxis again. In literature it's reported only one case of vaginal delivery, by Hardy et al. [6], in the other cases an emergent or elective cesarean section was performed. Fetal anemia could be secondary to acute massive maternal epistaxis refractory to conservative management. In few cases, pregnancy termination represents the best solution, because maternal changes in volemia and nasal mucosae stops at the same time.

 

 

Patient and observation Up    Down

A 26 years old nulliparous woman presented to our observation for severe right-sided epistaxis, non self-limiting. She had few episodes in the previous two weeks of epistaxis, even 3-4 per day, usually stopping spontaneously. She reported a negative ENT consultation except for mild hyperemia of nasal mucosa. The pregnancy was unremarkable, considered at low risk, at 39.6 weeks of gestation. Her familiar and personal history was negative for blood coagulopathies and hypertension. We tried to stop severe epistaxis with nasal packing and intravenous tranexamic acid. On the basis of the failure of our procedures an otolaryngologist performed an endoscopy identifying bleeding enlarged vessels. Nasal packing with hemostatic sponge was successful, the pregnant woman was admitted to ob&gyn department. Her hemoglobin levels dropped down to 6 mg/dl and she needed 4 red cell packs. The day after her right nostril despite the tampons started bleeding again. She was referred to otolaryngologist who packed again the nose, bilaterally and used hemostatic glue. After 2 more days she started bleeding again, her nose was again packed with glue and tampons and further 2 red cell packs were given. The obstetric scan revealed biometry at 40th centile, the Bishop score was 5, so we decided to induce labour after obtaining her informed written consent. The labour induction was performed with intravaginal prostaglandins (10 mg dinoprostone). After 18 hours the labour seemed to proceed well with cervical dilatation of 6 cm, level of head 0, but the cardiotocography (CTG) trace revealed anomalies that after 1 hour induced the shift versus cesarean section. No epistaxis happened during labour nor during cesarean section. Two days after nasal tampons were removed, the patient was discharged the day after. One month later the woman reported general good health and no epistaxis episodes, nor mild nor massive.

 

 

Discussion Up    Down

Epistaxis in pregnancy is not so uncommon and self-limiting, is more than three-times than in non-pregnant women [10]. However, when it occurs in the third trimester it could become life-threatening and a severe deal for obstetricians.. Operative ENT (ear, nose, throat) management is generally requested, even if there is limited evidence regarding the correct approach of severe epistaxis in pregnancy, complicated by the evidence that certain products are contraindicated (bismuth iodophorm paraffine gauzes, soaked ribbon gauzes) (Table 2) [8]. When termination of epistaxis is achieved, the further management depends on gestational age. When maternal and fetal conditions are good enough to wait, conservative management is to be preferred, in order to avoid preterm birth risks, but if the gestational age is near to term, it's evaluable delivery induction or elective cesarean section. Delivery induction is possible when cervix is favourable, using vaginal prostaglandins or oxytocin infusion, if Bishop score is 0-3 a planned cesarean section is to preferred.

 

 

Conclusion Up    Down

Hormonal changes during pregnancy affects nasal physiology; oestrogens cause vascular congestion, mucosal oedema and recurrent rhinitis (rhinitis of pregnancy) [11-13] in 20% of pregnant women. Estrogens could also have indirect effects on vascular wall by regulating NO signaling pathway (i.e. VEGF, VEGFR-2) [8]. Meanwhile progesterone provokes an increase of blood volume, which could cause an augmentation of vascular changes with severe epistaxis, in the absence of coagulative disorders or organic nasal abnormalities (polyps). Even the placenta contributes to the risk of epistaxis, releasing placental growth hormone that determines systemic effects such as vasodilatation. Last but not least immunological changes could lead to nasal hypersensitivity [11]. When severe epistaxis occurs in pregnancy a multidisciplinary approach is recommended, by obstetricians, ENT specialists [8]. The management could be conservative or surgical. The goal is to obtain control of blood loss in order to going on safely the pregnancy or to plan an elective cesarean section or labour induction.

 

 

Competing interests Up    Down

The authors declare no competing interests.

 

 

Authors’ contributions Up    Down

Laura Giambanco wrote the case report up; Vito Iannone researched literature; Maddalena Borriello followed the patient during her admission; Giuseppe Scibilia and Paolo Scollo reviewed the manuscript.

 

 

Tables  Up    Down

Table 1: care reports published

Table 2: acute epistaxis in pregnancy: management options (8, modified)

 

 

References Up    Down

  1. El Goulli M, Chelli M. Severe epistaxis during pregnancy: a case history. J Gynecol Obstet Biol Reprod. 1979; Jul-aug 8(5): 437-9. PubMed | Google Scholar

  2. Green LK, Green RS, Harris RE. Life-threatening epistaxis associated with pregnancy. Am J of Obstet & Gynecol. 1974; 120(8): 1113-1114. PubMed | Google Scholar

  3. Howard DJ. Life-threatening epistaxis in pregnancy. The J of Laringoloy & Otology. 1985; 99(1): 95-96. PubMed | Google Scholar

  4. Braithwaite JM, Encomides DL. Severe recurrent epistaxis causing antepartum fetal distress. Int J Obstet & Gynecol. 1995; 50(2): 197-198. PubMed | Google Scholar

  5. Cooley SM, Geary M, O'Connell MP, Keane DP. Hypovolaemic shock secondary to epistaxis in pregnancy. J of Obeste & Gynecol. 2002; 22(2): 229-230. PubMed | Google Scholar

  6. Hardy JJ, Connolly CM, Weir CJ. Epistaxis in pregacy-not to be sniffed at. International Journal of Obstetric Anesthesia. 2008; 17(1): 94-95. PubMed | Google Scholar

  7. Cornthwaite K, Varadharajan K, Oyarzabal M, Watson H. Management of prolonged epistaxis in pregnancy: case report. The Journal of Laringology & Otology. 2013; 127(8): 811-813. PubMed | Google Scholar

  8. Crunkhorn REM, Mitchell-Innes A, Mufazzar J. Torrential epistaxis in the third trimester: a management conundrum. BMJ case reports. 2014; 2014: 203892. PubMed | Google Scholar

  9. Piccioni MG, Derme M, Salerno L, Morrocchi E, Pecorini F, Porpora MG et al. Management of severe epistaxis during pregnancy: a case report and review of the literature. Case Reports in Ob Gyn 2019; 5825309: 3. Google Scholar

  10. Dugan-Kim M, Connell S, Stika C. Epistaxis of pregnancy and association with postpartum hemorrhage. Obstet Gynecol. 2009; 114(6): 1322-5. PubMed | Google Scholar

  11. Osol G, Ko NL, Mandalà M. Plasticity of the maternal vasculature during pregnancy. Annu Rev Physiol. 2019; 81: 89-111. PubMed | Google Scholar

  12. Choudary S, MacKinnon CA, Morrissey GP et al. A case of giant nasal pyogenic granuloma gravidarum. J Craniofac Surg. 2005; 16(2): 319-21. PubMed | Google Scholar

  13. Zarrinneshan A, Zapanta PE, Wall SJ. Nasal pyogenic granuloma. Otolaryngol Head Neck Surg. 2007; 136(1): 130-1. PubMed | Google Scholar